Vitamin-C-megaskorbicka-liecba.pdf - Zdravie.sk

Vitamín C a megaskorbická liečba – zabudnutý poklad 394 / 436
Zdroje
[1107] Suzuki H, Higuchi T, Sawa K, Ohtaki S, Horiuchi Y. "Endemic coast goitre" in Hokkaido, Japan. Acta
Endocrinol (Copenh). 1965 Oct;50(2):161-76. PMID:4158495.
[1108] Clements FW. Goitre prophylaxis by addition of potassium iodate to bread. Experience in Tasmania. Lancet.
1970 Mar 7;1(7645):489-92. PMID:4190178.
[1109] Jaffe R. Functional Lab Tests to Evaluate Immune Competencies in Chronic Illness and Chronic Infection.
Townsend letter 2009 Jan;(306):80-90. http://www.perque.com/pdfs/TownsendLtr_JaffeJanuary09.pdf
[1110] Jaffe R. How to do an Ascorbate (Vitamin C) Calibration Protocol (“C Flush”) to determine individual,
functional need for ascorbate. PERQUE LLC , 14 Pidgeon Hill Drive, Suite180, Sterling, VA 20165.
http://www.perque.com/pdfs/Pt_Ascorbate_Slush_FIN.pdf
[1111] González MJ, Miranda-Massari JR, Mora EM, Jiménez IZ, Matos MI, Riordan HD, Casciari JJ, Riordan NH,
Rodríguez M, Guzmán A. Orthomolecular oncology: a mechanistic view of intravenous ascorbate's
chemotherapeutic activity. P R Health Sci J. 2002 Mar;21(1):39-41. PMID:12013679.
[1112] Hoffer LJ. Vitamin Therapy in Schizophrenia. Isr J Psychiatry Relat Sci. 2008;45(1):3–10. PMID:18587164.
[1113] Klaidman L, Morales M, Kem S, Yang J, Chang ML, Adams JD Jr. Nicotinamide offers multiple protective
mechanisms in stroke as a precursor for NAD+, as a PARP inhibitor and by partial restoration of mitochondrial
function. Pharmacology 2003 Nov;69(3):150-7. PMID:14512702. DOI:10.1159/000072668.
[1114] Smythies JR. The role of ascorbate in brain: Therapeutic implications. J R Soc Med. 1996 May;89(5):241.
PMID:8778427. PMCID: PMC1295771.
[1115] Smythies JR. Oxidative reactions and schizophrenia: A review-discussion. Schizophr Res. 1997 Apr
11;24(3):357-64. PMID:9134597. DOI:10.1016/S0920-9964(97)00005-4.
[1116] Rebec GV. Ascorbate: An antioxidant neuroprotectant and extracellular neuromodulator. In: James R.
Connor, editor: Metals and oxidative damage in neurological disorders. Publisher: Springer. New York:
Plenum, 1997. 374 pages. ISBN-10: 030645534X. ISBN-13: 978-0306455346. pp.149–173.
[1117] Smythies J. Redox aspects of signaling by catecholamines and their metabolites. Antioxid Redox Signal.
2000 Fall;2(3):575-83. PMID:11229369. DOI:10.1089/15230860050192332.
[1118] Kinsman RA, Hood J. Some behavioral effects of ascorbic acid deficiency. Am J Clin Nutr. 1971
Apr;24(4):455-64. PMID:4397430. http://www.ajcn.org/cgi/reprint/24/4/455
[1119] Tucker BW, Tolbert BM, Halver JE, Balaban M. Brain ascorbate depletion as a response to stress. Int J
Vitam Nutr Res. 1987;57(3):289-95. PMID:3679701.
[1120] Reddy R, Keshavan M, Yao JK. Reduced plasma antioxidants in first-episode patients with schizophrenia.
Schizophr Res. 2003 Aug 1;62(3):205-12. PMID:12837516. DOI:10.1016/S0920-9964(02)00407-3.
[1121] Brody S. High-dose ascorbic acid increases intercourse frequency and improves mood: A randomized
controlled clinical trial. Biol Psychiatry. 2002 Aug 15;52(4):371-4. PMID:12208645.
[1122] Brody S, Preut R, Schommer K, Schürmeyer TH. A randomized controlled trial of high dose ascorbic acid
for reduction of blood pressure, cortisol, and subjective responses to psychological stress.
Psychopharmacology (Berl). 2002 Jan;159(3):319-24. Epub 2001 Nov 20. PMID:11862365.
DOI:10.1007/s00213-001-0929-6.
[1123] Hoffer A. Chronic schizophrenic patients treated ten years or more. J Orthomol Med. 1994;9:7-37.
http://orthomolecular.org/library/jom/1994/pdf/1994-v09n01-p007.pdf
[1124] Dakhale GN, Khanzode SD, Khanzode SS, Saoji A. Supplementation of vitamin C with atypical
antipsychotics reduces oxidative stress and improves the outcome of schizophrenia. Psychopharmacology
(Berl). 2005 Nov;182(4):494-8. Epub 2005 Oct 19. PMID:16133138. DOI:10.1007/s00213-005-0117-1.
[1125] Beauclair L, Vinogradov S, Riney SJ, Csernansky JG, Hollister LE. An adjunctive role for ascorbic acid in
the treatment of schizophrenia? J Clin Psychopharmacol. 1987 Aug;7(4):282-3. PMID:3624518.
[1126] Sandyk R, Kanofsky JD. Vitamin C in the treatment of schizophrenia. Int J Neurosci. 1993 Jan;68(1-2):67-
71. PMID:8063516.
[1127] Kemper KJ, Hood KL. Does pharmaceutical advertising affect journal publication about dietary
supplements? BMC Complement Altern Med. 2008 Apr 9;8:11. PMCID:PMC2322947. PMID:18400092.
http://www.biomedcentral.com/1472-6882/8/11
[1128] Fradkin JE, Wolff J. Iodide-Induced Thyrotoxicosis. Medicine (Baltimore). 1983 Jan;62(1):1-20.
PMID:6218369.
[1129] Lugol JGA. Mémoire sur l’emploi de l’iode dans les maladies scrophuleuses. Paris, 1829.
[1130] Sticht G, Käferstein H. Bromine. In: Handbook on Toxicity of Inorganic Compounds – Seiler HG and Sigel,
H Editors, Marcel Dekker Inc, 143-151, 1988.
[1131] Bulman RA. Iodine. In: Handbook on Toxicity of Inorganic Compounds – Seiler HG and Sigel, H Editors,
Marcel Dekker Inc, 327-337, 1988.
[1132] Stewart JC, Vidor GI. Thyrotoxicosis induced by iodine contamination of food-a common unrecognized
condition? Br Med J. 1976 Feb 14;1(6006):372-5. PMID:946162. PMCID: PMC1638791.
[1133] Furudate S, Nishimaki T, Muto T. 125I uptake competing with iodine absorption by the thyroid gland
following povidone-iodine skin application. Exp Anim. 1997 Jul;46(3):197-202. PMID:9250480.
DOI:10.1538/expanim.46.197. http://www.jstage.jst.go.jp/article/expanim/46/3/46_197/_article/-char/en
[1134] Philippou G, Koutras DA, Piperingos G, Souvatzoglou A, Moulopoulos SD. The effect of iodide on serum
thyroid hormone levels in normal persons, in hyperthyroid patients, and in hypothyroid patients on thyroxine
replacement. Clin Endocrinol (Oxf). 1992 Jun;36(6):573-8. PMID:1424182.
[1135] Abraham GE. The Wolff-Chaikoff Effect: Crying Wolf? The Original Internist, 2005;12(3):112-8. ISSN 1529-
4722. http://www.optimox.com/pics/Iodine/pdfs/IOD04.pdf
[1136] Konno N, Yuri K, Miura K, Kumagai M, Murakami S. Clinical Evaluation of the Iodide/Creatinine Ratio of
Casual Urine Samples as an Index of Daily Iodide Excretion in a Population Study. Endocr J. 1993
Feb;40(1):163-9. PMID:7951490.